Shorter-course treatment for Mycobacterium ulcerans disease with high-dose rifamycins and clofazimine in a mouse model of Buruli ulcer

Starting in 2004, the standard regimen for treatment of Buruli ulcer (BU) recommended by the World Health Organization has been daily treatment for eight weeks with rifampin (RIF) and streptomycin. Based on recent clinical trials, treatment with an all-oral regimen of RIF and clarithromycin (CLR) ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Converse, Paul J., Almeida, Deepak V., Tasneen, Rokeya, Saini, Vikram, Tyagi, Sandeep, Ammerman, Nicole C., Li, Si-Yang, Anders, Nicole M., Rudek, Michelle A., Grosset, Jacques H., Nuermberger, Eric L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6107292/
https://www.ncbi.nlm.nih.gov/pubmed/30102705
http://dx.doi.org/10.1371/journal.pntd.0006728

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6107292/
https://www.ncbi.nlm.nih.gov/pubmed/30102705
http://dx.doi.org/10.1371/journal.pntd.0006728

Ejemplares similares